/ A NOVEL CO-AMORPHOUS OF SACUBITRIL CALCIUM / VALSARTAN

摘要

It is to provide a new sacubitril calcium/valsartan co-amorphous form that overcomes the low water solubility and ease of formulation of sacubitril/valsartan sodium 2.5 hydrate, which is currently used as a treatment for chronic heart failure.